Literature DB >> 2031940

Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements.

E Proksch1, P M Elias, K R Feingold.   

Abstract

Recent studies have shown that epidermal cholesterol synthesis is regulated by HMG CoA reductase activity and that this activity is modulated by changes in the cutaneous permeability barrier. Here, we quantitated HMG CoA reductase activity after acute and chronic barrier disruption in the upper and lower layers of murine epidermis. In unperturbed epidermis, 13 and 87% of enzyme activity localized to the upper and lower epidermis, respectively, with the majority of activity in the stratum basale. Acute barrier disruption with either acetone or sodium dodecylsulfate provoked an increase in HMG CoA reductase activity (54% and 30%) in the lower layers, but only a small change in the upper layers. However, the activation state of the enzyme was increased 50% in the upper epidermis. Correction of barrier function by occlusion with an impermeable Latex wrap prevented the increase both in enzyme activity and activation state. After chronic barrier disruption; i.e., essential fatty acid deficient (EFAD) diet, HMG CoA reductase activity was increased in the upper epidermis (161%); a change prevented by occlusion. These results show: (1) that HMG CoA reductase activity is present in both the upper and lower cell layers; (2) that acute insults to barrier integrity stimulate enzyme activity in both the upper and lower epidermis; and (3) that chronic insults provoke an increase in enzyme activity in the upper layers. These studies provide further insights into the linkage of the permeability barrier with epidermal cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2031940     DOI: 10.1016/0005-2760(91)90126-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.

Authors:  L C Wood; S M Jackson; P M Elias; C Grunfeld; K R Feingold
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Content of the different lipid classes in psoriatic scale.

Authors:  S Motta; S Sesana; R Ghidoni; M Monti
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.

Authors:  J M Jensen; S Schütze; M Förl; M Krönke; E Proksch
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

4.  Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.

Authors:  W M Holleran; W N Gao; K R Feingold; P M Elias
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.

Authors:  W M Holleran; Y Takagi; G K Menon; G Legler; K R Feingold; P M Elias
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  By protecting against cutaneous inflammation, epidermal pigmentation provided an additional advantage for ancestral humans.

Authors:  Tzu-Kai Lin; Mao-Qiang Man; Katrina Abuabara; Joan S Wakefield; Hamm-Ming Sheu; Jui-Chen Tsai; Chih-Hung Lee; Peter M Elias
Journal:  Evol Appl       Date:  2019-09-24       Impact factor: 5.183

7.  Mutations in 3β-hydroxysteroid-δ8, δ7-isomerase paradoxically benefit epidermal permeability barrier homeostasis in mice.

Authors:  Erle Dang; George Man; Dale Lee; Debbie A Crumrine; Theodora M Mauro; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2020-11-30       Impact factor: 3.960

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.